Neurotech Secures Ethics Approval for Study of Cannabis-Based Drug Candidate in Adults; Shares Up 8%
Neurotech Secures Ethics Approval for Study of Cannabis-Based Drug Candidate in Adults; Shares Up 8%
神經科技獲得倫理審批，進行以大麻股爲基礎的藥物候選者在成人中的研究；股價上漲8%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間